SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Rayonier announced the permanent appointment of Ryan M. Daniels as Senior Vice President, Wood Products, effective immediately, converting his interim role (held since March 2026) to a permanent position. The Board approved the appointment on July 16, 2026, with a compensation package including $450,000 base salary, 65% cash bonus eligibility, and severance plan participation.
View raw filing on EDGAR →The Company issued a press release on July 17, 2026 announcing second quarter and year-to-date 2026 financial results, including net income of $2.208 billion ($10.26 per diluted share) for Q2 2026 and core income of $2.160 billion ($10.04 per diluted share). The disclosure includes detailed consolidated and segment financial metrics, combined ratios, underwriting performance, and capital allocation activities. This is a standard quarterly earnings release furnished as Exhibit 99.1, typical of Item 2.02 disclosures.
View raw filing on EDGAR →Truist Financial Corporation disclosed its second quarter 2026 financial results via press release on July 17, 2026, reporting net income available to common shareholders of $1.5 billion, diluted EPS of $1.23 (up 37% year-over-year), and key performance metrics including ROCE of 10.4% and ROTCE of 15.4%. The filing includes the Earnings Release, Quarterly Performance Summary, and Earnings Release Presentation as exhibits, which is the standard format for quarterly earnings disclosures under Item 2.02.
View raw filing on EDGAR →WaFd, Inc. announced quarterly earnings for the quarter ended June 30, 2026 via press release on July 16, 2026, disclosing net income of $66.1 million and diluted earnings per share of $0.84. The filing explicitly states this information is being furnished under Item 2.02 (Results of Operations and Financial Condition), with the press release attached as Exhibit 99.1 containing detailed financial results, balance sheet data, and performance metrics.
View raw filing on EDGAR →Uniti Group completed a private offering of $1,140,710,000 aggregate principal amount of secured fiber network revenue term notes on July 15, 2026, consisting of three classes (A-2, B, and C) with varying interest rates and a June 2033 anticipated repayment date. This represents a material capital-raising transaction for the company's fiber-to-the-home securitization program.
View raw filing on EDGAR →This Item 5.07 discloses the results of a special stockholder meeting held on July 16, 2026, where shareholders voted on three proposals, including approval of a merger agreement with KL Criss Cross Intermediate, LLC. Proposal 1 (the Merger Agreement Proposal) was approved with 23,356,105 votes in favor versus 12,309 against, and Proposal 2 (Advisory Merger-Related Compensation) was also approved. This is a classic shareholder vote results disclosure that is material because it confirms stockholder approval of a transformative merger that will result in the company being delisted from NASDAQ and deregistered under the Securities Exchange Act.
View raw filing on EDGAR →Jill Larsen was appointed to OpenText's board of directors effective immediately on July 17, 2026. Larsen is a seasoned executive with extensive HR and organizational leadership experience at major technology companies including Synopsys, Cisco, EMC, and PTC. The appointment was announced concurrently with the resignation of director Kristen Ludgate.
View raw filing on EDGAR →The disclosure announces a four-unit RIO 360 order from a high-profile pop culture brand customer through AITX's dealer channel. This is a material operational/commercial event demonstrating product adoption and dealer channel effectiveness, but does not fit the specific taxonomy categories (not earnings, M&A, impairment, litigation, etc.). The company explicitly notes this order "illustrates the effectiveness of its dealer channel strategy" and represents "commercial momentum," making it material to investors assessing the company's operational performance and market traction.
View raw filing on EDGAR →Kimbell Royalty Partners entered into a Purchase and Sale Agreement on July 16, 2026, to acquire mineral interests, royalty interests, and partnership interests in oil and gas properties for approximately $215.4 million in total consideration ($74.9 million cash plus 9.5 million newly issued units representing 2,568 net royalty acres across premier basins). The transaction is expected to close on August 21, 2026, and is immediately accretive to distributable cash flow per unit.
View raw filing on EDGAR →Nebius announced entry into its first senior secured debt facility for approximately $775 million, backed by GPU infrastructure and contracted cash flows, maturing October 31, 2030, and priced at SOFR + 2.50%. This is a material creation of a direct financial obligation that would affect a reasonable investor's assessment of the company's capital structure and financing strategy.
View raw filing on EDGAR →Sony announced the disposal of 1,142,196 treasury shares upon vesting of restricted stock units (RSUs) granted to directors, officers, and employees under its stock compensation plan. The announcement details the vesting mechanics, allottees (including 1 director and 1 corporate executive officer of the Corporation), and the total disposal price of approximately 3.9 billion yen. This is a material disclosure of compensatory arrangements involving equity grants and their settlement, falling squarely within exec_compensation rather than a routine administrative matter.
View raw filing on EDGAR →Vision Marine Technologies announced unaudited financial results for the three-month and nine-month periods ended May 31, 2026, reporting Q3 revenue of $18.4 million (27% sequential growth), nine-month revenue of $48.6 million, gross profit of $11.8 million at 24.3% margin, and a net loss of $11.9 million.
View raw filing on EDGAR →Vision Marine completed an at-the-market (ATM) equity offering program that raised approximately US$16.3 million in gross proceeds through the issuance of 6,380,235 common shares, bringing total outstanding shares to 6,530,460.
View raw filing on EDGAR →This announcement discloses the grant of 16,220,972 restricted share units (RSUs) to 438 employees under the 2026 Share Incentive Plan on July 17, 2026, representing approximately 0.36% of total issued shares. The disclosure details vesting schedules, performance conditions, clawback mechanisms, and the rationale for the grants—all hallmarks of executive and employee compensation arrangements. While the grantees are not named executives, the scale and structure of this equity grant constitute a material compensatory arrangement requiring disclosure under Hong Kong Listing Rules 17.06A–C.
View raw filing on EDGAR →Csquare completed its initial public offering on July 17, 2026, selling 50 million shares at $21.00 per share for net proceeds of $1,010 million under an underwriting agreement with Morgan Stanley and TD Securities. The IPO included concurrent entry into registration rights and stockholders agreements with Brookfield, granting board nomination rights and significant governance protections, representing a material change of control and capital structure event.
View raw filing on EDGAR →Transcode Therapeutics amended the Certificate of Designation for Series C Preferred Stock, increasing the beneficial ownership limitation from 4.99% to 9.99% and correcting scrivener's errors. The amendment was approved by the Board and Series C holders.
View raw filing on EDGAR →IPG Photonics entered into a binding Put Option Agreement on July 16, 2026, to acquire 100% of Lumibird Medical for €300 million plus up to €50 million in contingent earnout consideration on a cash-free, debt-free basis, with expected closing in Q4 2026. The acquisition is expected to expand IPG's Advanced Solutions portfolio, create a scaled medical laser platform, and be accretive to gross margin, EBITDA, and adjusted EPS.
View raw filing on EDGAR →The filing discloses an amendment to a previously announced merger agreement between Lisata Therapeutics and Kuva Labs Inc., extending the Outside Date from July 17, 2026 to July 21, 2026. This is a material modification to an existing M&A transaction that would affect a reasonable investor's assessment of the deal's status and timeline.
View raw filing on EDGAR →South Plains Financial issued a press release on July 17, 2026 announcing its financial results for the second quarter ended June 30, 2026, disclosing net income of $19.0 million, diluted EPS of $0.96, and other key financial metrics.
View raw filing on EDGAR →South Plains Financial declared a quarterly cash dividend of $0.18 per share on outstanding common stock, payable August 10, 2026 to shareholders of record as of July 27, 2026.
View raw filing on EDGAR →This press release announces Evaxion's presentation of three-year clinical efficacy data for its lead cancer vaccine candidate EVX-01 at the ESMO Congress 2026. The disclosure highlights positive trial results (75% ORR, 92% durability at two years, and new stand-alone therapy data) that are material to investors assessing the company's clinical progress and commercial prospects. While not a discrete event like an approval or M&A transaction, the announcement of significant clinical milestone data from an ongoing phase 2 trial is a material operational/clinical development event that would affect a reasonable investor's assessment of the registrant's pipeline and competitive position.
View raw filing on EDGAR →The 6-K discloses an ongoing shareholder activism campaign initiated by shareholders who filed a Schedule 13D on July 10, 2026, demanding removal of all current board members except the CEO and replacement with activist nominees. While the filing also mentions an increase in an at-the-market offering amount, the substantive disclosure is the risk factors update addressing the material governance threat posed by the activist campaign, including potential proxy contests, board composition changes, and operational disruption. This is a governance event—specifically shareholder activism and potential proxy contest risk—that does not fit the specific categories of exec_departure, exec_appointment, or shareholder_vote_results (no vote has occurred yet), making governance_other the appropriate classification.
View raw filing on EDGAR →The exhibit announces the appointment of Dr. Shlomit Chappel-Ram as an independent director to QTREX's Board, effective July 14, 2026. The disclosure emphasizes her deep technical expertise in AME technology from her prior role as VP of R&D at Nano Dimension (the source of QTREX's recently acquired AME platform), making her appointment material to investors evaluating the company's ability to execute on its quantum connectivity strategy. This is a clear exec_appointment event.
View raw filing on EDGAR →RTB Digital announced a comprehensive technology partnership with Mario Nawfal, a major digital media figure with over 1 billion monthly video views, to host his non-social digital platform (marionawfal.com) on RTB's integrated technology stack. This is a material strategic partnership involving a high-profile media partner and represents a significant operational milestone for the company's enterprise media platform business, but does not fit the specific categories of M&A activity, debt issuance, or other defined event types.
View raw filing on EDGAR →The filing discloses the appointment of Thomas Mathiasmeier to the Board of Directors as a Class II Director on July 16, 2026, and his concurrent appointment to the Audit Committee. While the disclosure also mentions compensatory arrangements (a pro-rated restricted stock award of 477 shares), the principal disclosed action is the appointment itself. Mathiasmeier's substantial experience as President of Global Gas, Power & Emerging Markets at ConocoPhillips and his industry expertise make this a material governance event affecting the composition and expertise of the Board.
View raw filing on EDGAR →MakeMyTrip announced a proposed initial public offering and listing of its wholly-owned subsidiary MMT India on Indian stock exchanges. This constitutes a material capital-structure transaction involving a partial divestiture of equity in a subsidiary while retaining control, with proceeds to strengthen cash position and fund strategic initiatives. The announcement explicitly states the IPO will involve sale of equity shares by MakeMyTrip and ibibo Holdings, and that MMT India will remain a consolidated subsidiary post-IPO.
View raw filing on EDGAR →This exhibit is the 2026 Omnibus Share Incentive Plan adopted by the Board on July 13, 2026. It establishes a comprehensive equity compensation framework authorizing grants of options, restricted shares, share units, and cash-based awards to employees, consultants, and directors. The plan document itself—setting forth the terms, conditions, and administration of compensatory arrangements—constitutes a material disclosure of executive and employee compensation arrangements under Item 5.02(e) equivalent disclosure obligations for foreign private issuers.
View raw filing on EDGAR →This press release announces FDA approval of Sarclisa Escena (isatuximab-irfc) subcutaneous formulation with an on-body injector (CirCLIQ OBI), representing a significant product innovation and regulatory milestone for Sanofi's oncology franchise. The approval expands the delivery options for an existing drug across multiple approved indications in multiple myeloma treatment, supported by the pivotal IRAKLIA phase 3 study demonstrating non-inferiority to IV formulation. While not a discrete M&A, debt, or governance event, this regulatory approval of a novel delivery mechanism for a cornerstone oncology product materially affects the commercial potential and competitive positioning of Sarclisa, which has already been prescribed to over 70,000 patients worldwide.
View raw filing on EDGAR →Autoliv issued a press release on July 17, 2026 announcing its financial results for Q2 2026, including net sales of $2,803 million, operating margin of 6.8%, adjusted operating margin of 9.6%, diluted EPS of $1.35, and full-year 2026 guidance.
View raw filing on EDGAR →The exhibit announces preliminary unaudited Q2 2026 financial results (subscription revenue US$63.5–63.7M, total revenue US$68.3–68.5M, Adjusted EBITDA US$10.9–11.1M) alongside revised Q3 2026 and FY2026 guidance. While the exhibit also discloses a substantial issuer bid (share repurchase), the primary substantive disclosure is the earnings announcement with forward-looking guidance, which is material to investor assessment of financial performance and future prospects.
View raw filing on EDGAR →Kalaris disclosed positive Phase 1a clinical trial data for its lead candidate TH103 in neovascular AMD, including expanded cohort results (17 treatment-naïve, 3 treatment-experienced patients) showing improvements in vision (9.2-letter BCVA improvement), retinal anatomy (118µm OCT improvement), extended time-to-retreatment, and favorable pharmacokinetic findings with extended intraocular retention and improved safety profile.
View raw filing on EDGAR →VivoSim Labs entered into a Securities Purchase Agreement on July 16, 2026, to issue pre-funded warrants and common warrants to purchase up to 4,705,883 shares of common stock at $0.85 per share for approximately $4.0 million in gross proceeds. The unregistered securities are issued under Section 4(a)(2) and Regulation D exemptions, with the company agreeing to file a registration statement for resale. The transaction includes amendment of existing Armistice warrants downward from $9.60 to $0.85 per share, creating substantial warrant overhang and dilution to existing shareholders.
View raw filing on EDGAR →LAGO Evergreen Credit disclosed an unregistered sale of 666,496 common shares at $25.37 per share for an aggregate purchase price of $16.9 million to accredited investors in a private placement. The transaction is explicitly exempt under Section 4(a)(2) of the Securities Act and Regulation D, which are the standard exemptions for private placements. This is a classic dilutive issuance that would materially affect a reasonable investor's assessment of share ownership and capital structure.
View raw filing on EDGAR →The Board rejected director Michael D. Magill's resignation following his failure to receive majority shareholder support in the uncontested election at the 2026 Annual Meeting, with the Board disputing ISS's independence analysis and emphasizing Magill's qualifications despite the shareholder vote outcome.
View raw filing on EDGAR →The filing discloses material litigation filed on July 6, 2026, in New Jersey Superior Court challenging the Merger on grounds of materially incomplete and misleading proxy disclosures. The plaintiff seeks injunctive relief to enjoin the stockholder vote scheduled for July 23, 2026, and a motion for preliminary injunction was filed on July 13, 2026. This litigation directly threatens the timing and completion of a material M&A transaction and would affect a reasonable investor's assessment of deal risk.
View raw filing on EDGAR →The filing discloses two executive departures: Richard Lowenthal's resignation from the Board of Directors effective immediately on July 15, 2026, and Sarina Tanimoto, M.D. (Chief Medical Officer), ceasing employment under a termination without cause on the same date. While severance and compensatory arrangements are mentioned, the principal disclosed action centers on these two individuals leaving their roles. The departure of a CMO is material to a pharmaceutical company's operations and investor assessment.
View raw filing on EDGAR →EyePoint settled potential False Claims Act and related civil violations with the DOJ, OIG-HHS, and DHA involving alleged improper sales and marketing practices for DEXYCU® from 2019–2023. The settlement requires payment of $4.68 million plus interest and attorneys' fees, and imposes a five-year Corporate Integrity Agreement with significant compliance obligations. This is a material government settlement resolving regulatory and civil liability exposure.
View raw filing on EDGAR →The Company entered into a Fourth Amendment to its credit facility, increasing the total facility amount from $650 million to $750 million and expanding the accordion provision from $800 million to $1 billion maximum, representing a material expansion of the Company's direct financial obligations and borrowing capacity.
View raw filing on EDGAR →Four Leaf Acquisition Corp terminated its material Business Combination Agreement with XYDD, effective July 15, 2026, due to regulatory review under PRC law. The company is now pursuing an alternative business combination with Data443.
View raw filing on EDGAR →Data443 agreed to issue a US$2,000,000 promissory note to XYDD as compensation for terminating the business combination agreement, with 15% per annum interest if unpaid and a conversion feature into equity representing up to 19.99% of post-combination shares.
View raw filing on EDGAR →The 6-K discloses entry into a Securities Purchase Agreement on July 17, 2026, for a private placement of 5,333,331 Class A ordinary shares and 5,333,331 warrants to non-U.S. persons at $0.30 per share/warrant, generating approximately $1.6 million in gross proceeds. This is a classic dilutive equity issuance under Regulation S, material to investors as it increases share count and dilutes existing shareholders' ownership.
View raw filing on EDGAR →MAAS announced entry into an agreement to sell its entire 49% equity interest in Laixi Intelligent for US$17 million in cash. This is a material asset disposition and divestiture of a non-core business unit (unmanned car wash). While the transaction is framed as a strategic portfolio optimization to refocus on AI, it represents a significant financial event involving the sale of a subsidiary stake. The event does not fit the specific `ma_activity` category (which typically covers acquisitions, mergers, or changes of control) but is clearly a material financial transaction involving the disposition of an equity interest, making `financial_other` the most appropriate classification.
View raw filing on EDGAR →The press release discloses receipt of a Nasdaq Listing Qualifications Staff Determination Letter on July 14, 2026, notifying the Company that it failed to maintain the minimum bid price requirement of $1.00 per share for 30 consecutive business days. The Company has been granted a 180-calendar-day compliance period (until January 11, 2027) to regain compliance, with potential for an additional 180-day period if certain conditions are met. This is a material delisting risk disclosure under Nasdaq Listing Rule 5810(b), which requires prompt disclosure of deficiency notifications.
View raw filing on EDGAR →The filing discloses two significant executive departures: Ajay Kumar Dhadha resigned as Chairman and Director effective June 30, 2026, and Guy Ofir resigned as Chief Financial Officer, General Counsel, and Director effective July 16, 2026. While the section also mentions the appointment of Uri Tadelis as CFO, the principal disclosed actions center on the departures of two senior officers, including the CFO and Board Chairman. Both resignations are stated to be voluntary and without disagreement with the Company.
View raw filing on EDGAR →Thunder Power Holdings reincorporated from Delaware to Nevada on June 23, 2026, with stockholders holding approximately 62% of voting power approving the change by written consent on May 26, 2026. The reincorporation resulted in material modifications to certain stockholder rights due to differences between Delaware and Nevada law, though the company's board, management, business, operations, and third-party contracts remained unchanged.
View raw filing on EDGAR →Aditxt entered into Amendment No. 2 to a Note Purchase Agreement on July 16, 2026, allowing a new investor to join and issuing two Additional Notes as senior secured debt instruments backed by substantially all assets of its subsidiary Ignite and pledged equity.
View raw filing on EDGAR →The filing discloses the Board's decision to initiate an orderly wind down of the Company's operations, including a reduction in force and maintenance of only a core group of employees necessary for the wind down. While the filing is captioned Item 2.05 (Costs Associated with Exit or Disposal Activities), the primary disclosed action is the operational restructuring and workforce reduction in connection with the Company's decision to cease operations, with all Directors and Officers resigning effective August 5, 2026. This constitutes a material workforce reduction and operational restructuring event.
View raw filing on EDGAR →This is a press release disclosing Highway Holdings' fiscal fourth quarter and full-year 2026 financial results (year ended March 31, 2026), including net sales, gross profit, net loss per share, and consolidated financial statements. The disclosure is material as it reports significant deterioration: full-year net sales declined 35% to $4.8M, the company swung from net income of $106K to a net loss of $1.5M, and recorded a $125K impairment charge due to adverse business conditions and Myanmar political unrest. These results would materially affect a reasonable investor's assessment of the registrant's financial condition and performance.
View raw filing on EDGAR →CO2 Energy Transition Corp., a SPAC, announced entry into a non-binding letter of intent for an initial business combination with a Texas-based oil and gas company focused on lithium and strontium recovery. The press release explicitly states the parties "intend to negotiate and enter into definitive agreements for the proposed business combination" with a target execution date of September 16, 2026. This constitutes material M&A activity under Item 1.01, as it represents the SPAC's pursuit of its stated purpose and would result in a change of control or significant business combination.
View raw filing on EDGAR →The filing discloses the appointment of Stephen N. Cannon as a Class II director of Archimedes Tech SPAC Partners III Co., effective July 13, 2026, with concurrent appointment to the audit, compensation, and nominating committees. The disclosure centers on the principal action of a person taking a board role, making this an exec_appointment event. The appointment is material as it involves a director with extensive SPAC experience joining the board of a blank-check company.
View raw filing on EDGAR →